Excitotoxic and post-ischemic neurodegeneration: Involvement of transglutaminases

Amino Acids

Volumn 27, Issue 3-4, 2004, Pages 373-379

  Caccamo, D ^a   Campisi, A ^b   Curro M ^a   Li Volti, G ^b   Vanella, A ^b   Ientile, R ^a,c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Astroglial cells; Cerebellar granule neurons; Excitotoxicity; Ischemia; Neurodegenerative diseases; Transglutaminases

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; AMPA RECEPTOR ANTAGONIST; CALCIUM ION; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ASTROCYTE; BRAIN CELL; BRAIN ISCHEMIA; CALCIUM TRANSPORT; CELL DAMAGE; CROSS LINKING; EXCITOTOXICITY; GRANULE CELL; HUMAN; MOLECULAR MECHANICS; NERVE CELL LESION; NEUROLOGIC DISEASE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; STRESS; UPREGULATION;

ANIMALS; BENZODIAZEPINES; BRAIN ISCHEMIA; CALCIUM; CELLS, CULTURED; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; NERVE DEGENERATION; NEUROTOXINS; RECEPTORS, N-METHYL-D-ASPARTATE; TRANSGLUTAMINASES;

EID: 12144255196     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-004-0117-1     Document Type: Review

References (52)

1. Ahlemeyer B, Kölker S, Zhu Y, Hoffmann GF, Krieglstein J (2002) Increase in glutamate-induced neurotoxicity by activated astrocytes involves stimulation of protein kinase C. J Neurochem 82: 504-515
2. Bonelli RM, Aschoff A, Niederwieser G, Heuberger C, Jirikowski G (2002) Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's disease. Neurobiol Dis 11: 106-110
3. Butterfield DA, Kanski J (2001) Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Aging Dev 122: 945-962
4. Campisi A, Caccamo D, Raciti G, Cannavo G, Macaione V, Currò M, Macaione S, Vanella A, Ientile R (2003) Glutamate-induced increases in transglutaminase activity in primary cultures of astroglial cells. Brain Res 978: 24-30
5. Carson DA, Ribeiro JM (1993) Apoptosis and disease. Lancet 341: 1251-1254
6. Cassarino DS, Bennett JP Jr (1999) An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res Rev 29: 1-25
7. Charles AC, Merrill JE, Dirksen ER, Sanderson MJ (1991) Intercellular signalling in glial cells: calcium waves and oscillations in response to mechanical stimulation and glutamate. J Neurosci 6: 983-992
8. Chen SH, Liu SH, Liang YC, Lin JK, Lin-Shiau SY (2001) Oxidative stress and c-Jun-amino-terminal kinase activation involved in apoptosis of primary astrocytes induced by disulfiram-Cu(2+) complex. Eur J Pharmacol 414: 177-188
9. Choi DW (1992) Excitotoxic cell death. J Neurobiol 23: 1261-1276
10. Chowdhury ZA, Barsigian C, Chalupowicz GD, Bach TL, Garcia-Manero G, Martinez J ( 1997) Colocalization of tissue transglutaminase and stress fibers in human vascular smooth muscle cells and human umbilical vein endothelial cells. Exp Cell Res 231: 38-49
11. Citron BA, Suo Z, SantaCruz K, Davies PJA, Qin F, Festoff BW (2002) Protein cross-linking, tissue transglutaminase, alternative splicing and neurodegeneration. Neurochem Int 40: 69-78
12. Condorelli DF, Dell'Albani P, Amico C, Kaczmarek L, Nicoletti F, Lukasiuk K, Stella AM (1993) Induction of primary response genes by excitatory amino acid receptor agonists in primary astroglial cultures. J Neurochem 60: 877-885
13. Condorelli DF, Conti F, Gallo V, Kirchhoff F, Seifert G, Steinhauser C, Verkhratsky A, Yuan X (1999) Expression and functional analysis of glutamate receptors in glial cells. Adv Exp Med Biol 468: 49-67
14. n-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability. J Neurochem 72: 889-899
15. n-expansion diseases? Neurochem Int 40: 53-67
16. Cox JA, Felder CC, Henneberry RC (1990) Differential expression of excitatory amino acid receptor subtypes in cultured cerebellar neurons. Neuron 4: 941-947
17. De Laurenzi V, Melino G (2001) Gene disruption of tissue transglutaminase. Mol Cell Biol 21: 148-155
18. Doble A (1999) The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 81: 163-221
19. Fesus L (1998) Transglutaminase-catalyzed protein cross-linking in the molecular program of apoptosis and its relationship to neuronal processes. Cell Mol Neurobiol 18: 683-694
20. Gentile V, Sepe C, Calvani M, Melone MA, Cotrufo R, Cooper AJ, Blass JP, Peluso G (1998) Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favoured with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases. Arch Biochem Biophys 352: 314-321
21. Grènard P, Bates MK, Aeschlimann D (2001) Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. J Biol Chem 276: 33066-33078
22. Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: Nature's biological glues. Biochem J 368: 377-396
23. Griffiths R, Ritchie L, Lidwell K, Grieve A, Malcolm CS, Frandsen A, Scott M, Meredith C (1998) Calcium influx via L-type voltage-gated channels mediates the delayed, elevated increases in steady-state c-fos mRNA levels in cerebellar granule cells exposed to excitotoxic levels of glutamate. J Neurosci Res 52: 641-652
24. Ientile R, Caccamo D, Macaione V, Torre V, Macaione S (2002) NMDA-evoked excitotoxicity increases tissue transglutaminase in cerebellar granule cells. Neuroscience 115: 723-729
25. Ientile R, Campisi A, Raciti G, Caccamo D, Currò M, Cannavò G, Li Volti G, Macaione S, Vanella A (2003) Cystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells. J Neurosci Res 74: 52-59
26. Igarashi S, Koide R, Shimohata T, Yamada M, Hayashi Y, Takano H, Date H, Oyake M, Sato T, Sato A, Egawa S, Ikeuchi T, Tanaka H, Nakano R, Tanaka K, Hozumi I, Inuzuka T, Takahashi H, Tsuji S (1998) Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet 18: 111-117
27. Jeitner TM, Bogdanov MB, Matson WR, Daikhin Y, Yudkoff M, Folk JE, Steinman L, Browne SE, Beal MF, Blass JP, Cooper AJ (2001) N(epsilon)-(gamma-L- glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease. J Neurochem 79: 1109-1112
28. Lai TS, Tucker T, Burke JR, Strittmatter WJ, Greenberg CS (2004) Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats. J Neurochem 88: 1253-1260
29. Lewen A, Matz P, Chan PH (2000) Free radical pathways in CNS injury. J Neurotrauma 17: 871-890
30. Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79: 1431-1536
31. Liu HN, Giasson BI, Mushynski WE, Almazan G (2002) AMPA receptor-mediated toxicity in oligodendrocyte progenitors involves free radical generation and activation of JNK, calpain and caspase 3. J Neurochem 82: 398-409
32. Lok J, Martin LJ (2002) Rapid subcellular redistribution of Bax precedes caspase-3 and endonuclease activation during excitotoxic neuronal apoptosis in rat brain. J Neurotrauma 19: 815-828
33. Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, Portera-Cailliau C (1998) Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res Bull 46: 281-309
34. Matute C, Alberdi E, Ibarretxe G, Sanchez-Gomez MV (2002) Excitotoxicity in glial cells. Eur J Pharmacol 447: 239-246
35. McNaughton LA, Hunt SP (1992) Regulation of gene expression in astrocytes by excitatory amino acids. Brain Res Mol Brain Res 16: 261-266
36. Meldrum BS (2000) Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130: 1007-1015
37. Melino G, Piacentini M (1998) Tissue transglutaminase in cell death: a downstream or a multifunctional upstream effector? FEBS Lett 430: 59-63
38. Nanda N, Iismaa SE, Owens WA, Husain A, Mackay F, Graham RM (2001) Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem 276: 20673-20678
39. Nicholas B, Smethurst P, Verderio E, Jones R, Griffin M (2003) Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity. Biochem J 371: 413-422
40. Olney JW (1986) Inciting excitotoxic cytocide among central neurons. Adv Exp Med Biol 203: 631-645
41. Paschen W, Röhn G, Schmidt-Kastner R (1990) Transglutaminase activity in reversible cerebral ischemia in the rat. Neurosci Lett 110: 232-236
42. Perry MJ, Mahoney SA, Haynes LW (1995) Transglutaminase C in cerebellar granule neurons: regulation and localization of substrate cross-linking. Neuroscience 65: 1063-1076
43. Piacentini M, Davies PJA, Fesus L (1994) Tissue transglutaminase in cells undergoing apoptosis. In: Tomei LD, Cope FO (eds) Apoptosis II: The molecular basis of apoptosis in disease. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp 143-163
44. Piacentini M, Farrace MG, Piredda L, Matarrese P, Ciccosanti F, Falasco L, Rodolfo C, Giammarioli AM, Verderio E, Griffin M, Malorni W (2002) Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress. J Neurochem 81: 1062-1072
45. Polakowska RR, Graf BA, Falciano V, LaCelle P (1999) Transcription regulatory elements of the first intron control human transglutaminase type I gene expression in epidermal keratinocytes. J Cell Biochem 73: 355-369
46. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298: 789-791
47. Snider BJ, Du C, Wei L, Choi DW (2001) Cycloheximide reduces infarct volume when administered up to 6 h after mild focal ischemia in rats. Brain Res 917: 147-157
48. Tenneti L, Lipton SA (2000) Involvement of activated caspase-3-like proteases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem 74: 134-142
49. Tucholski J, Johnson GVW (2002) Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner. J Neurochem 81: 780-791
50. Wiessner C, Sauer D, Alaimo D, Allegrini PR (2000) Protective effect of a caspase inhibitor in models for cerebral ischemia in vitro and in vivo. Cell Mol Biol 46: 53-62
51. Xia Y, Ragan RE, Seah EE, Michaelis ML, Michaelis EK (1995) Developmental expression of N-methyl-D-aspartate (NMDA)-induced neurotoxicity, NMDA receptor function, and the NMDA-R1 and glutamate-binding protein subunits in cerebellar granule cells in primary cultures. Neurochem Res 20: 617-629
52. Yu AC, Wong HK, Yung HW, Lau LT (2001) Ischemia-induced apoptosis in primary cultures of astrocytes. Glia 35: 121-130